Entry Detail



General Information

Database ID:exR0000186
RNA Name:ACTB
RNA Type:mRNA
Chromosome:chr7
Starnd:-
Coordinate:
Start Site(bp):5527148End Site(bp):5563784
External Links:ENSG00000075624



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACTN1
chr14
68874143
68979440
-
AIP
chr11
67483026
67491103
+
ACAT1
chr11
108116695
108147603
+
ACIN1
chr14
23058564
23095614
-
AC138894.1
chr16
28456371
28492098
-
ACTA2
chr10
88935074
88991339
-
AAMP
chr2
218264123
218270257
-
ADPGK
chr15
72751369
72785846
-
AC068946.2
chr2
219209772
219222738
-
AC104452.1
chr3
49416777
49429314
-
AC010132.3
chr7
42909273
42932174
-
ACTR10
chr14
58200080
58235636
+
ADAM8
chr10
133262420
133276868
-
ALDOA
chr16
30064164
30070457
+
AC011448.1
chr19
19516227
19536076
+
AC012184.2
chr16
70299194
70372582
+
AL109827.1
chr20
35632340
35674544
-
ABCF1
chr6
30571393
30597179
+
AC124312.1
chr15
24955034
25000276
+
AC098850.3
chr17
16690261
16804453
+
ACLY
chr17
41866917
41930542
-
ACTBL2
chr5
57480018
57482811
-
AC010463.1
chr19
17267418
17282966
+
AKIRIN1
chr1
38991276
39006059
+
ABCB7
chrX
75051048
75156732
-
AC010422.3
chr19
12643831
12648397
-
AC015813.2
chr17
57989038
58007246
-
ACTN4
chr19
38647649
38731589
+
AD000671.2
chr19
35739252
35745432
-
AL136295.4
chr14
24180395
24190416
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-367-3p
chr4
112647877
112647898
-
hsa-miR-7847-3p
chr11
1880105
1880125
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AD000090.1
chr19
35557956
35581954
+
AC013269.1
chr2
130530275
130537182
+
AC007326.5
chr22
18936411
18947741
+
AL139819.1
chr10
100335563
100346390
-
HOXC-AS2
chr12
53993810
53996785
-
AC087190.3
chr16
9104848
9113181
+
LINC01641
chr1
227393554
227431035
+
SNHG5
chr6
85650491
85678932
-
OIP5-AS1
chr15
41283990
41309737
+
AC091564.7
chr11
6610883
6616594
-
AC079466.1
chr19
28606688
28615229
+
SNHG6
chr8
66921684
66926398
-
SNHG22
chr18
49814023
49851059
+
AC139149.1
chr17
81514047
81527776
+
MIR155HG
chr21
25561909
25575168
+
AL023653.1
chrX
129794994
129796963
+
AC098850.4
chr17
16788057
16816540
+
AL356488.2
chr1
109100193
109100619
+
AC004943.1
chr16
72805998
72809872
+
AC016876.2
chr17
7581964
7584086
-
AC079781.5
chr7
97851688
97972985
-
GAS5
chr1
173858559
173868882
-
AL359924.1
chr1
237862175
237928321
+
LINC01896
chr18
78976555
78979074
-
AC055811.1
chr17
17167946
17185554
-
AC079949.1
chr12
127142029
127146532
-
ESRG
chr3
54632122
54639857
-
LINC00662
chr19
27681072
27794005
-
AL022311.1
chr22
37876148
37895563
+
TERC
chr3
169764520
169765060
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.